Evaluation of P-glycoprotein expression in human oral oncogenesis: Correlation with clinicopathological features

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 728-734

  Ralhan, Ranju ^a   Narayan, Murli ^a   Salotra, Poonam ^c   Shukla, Nootan K ^b   Chauhan, Shyam S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

^c SAFDARJUNG HOSPITAL CAMPUS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLYCOPROTEIN P;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MALE; MOUTH CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN INDUCTION; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; P-GLYCOPROTEIN; RETROSPECTIVE STUDIES;

EID: 0030873585     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<728::AID-IJC4>3.0.CO;2-U     Document Type: Article

References (24)

1. BERGH, J., NORBERG, T., SJORGREN, S., LINDGREN, A. and HOLMBERG, L., Complete sequencing of the p53 gene provides prognostic information in breast-cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature Med., 1, 1029-1034 (1995).
2. BIEDLER, J.L., Drug resistance: genotype versus phenotype. Thirty-second G.H.A. Clowes Memorial Award Lecture. Cancer Res., 54, 666-678 (1994).
3. CHIN, K.V., UEDA, K., PASTAN, I. and GOTTESMAN, M.M., Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science, 255, 459-462 (1992).
4. CLARKE, A.R., PURDIE, C.A., HARRISON, D.J., MORRIS, R.G., BIRD, C.C., HOOPER, M.L. and WYLLIE, A.H., Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362, 849-852 (1993).
5. DAFTARY, D.K., MURTI, P.R., BHONSLE, R.R., GUPTA, P.C., MEHRA, F.S. and PINDBORG, J.J., Risk factors and risk markers for oral cancer in high-risk areas of the world. In: N.W. Johnson (ed.), Oral cancer: the detection of patients and lesions at risk, pp. 29-63, Cambridge University Press, Cambridge (1991).
6. GOTTESMAN, M.M. and PASTAN, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
7. HONG, W.K., BROMER, R.H., AMATO, D.A., SHAPSHAY, S., VINCENT, M., VAUGHAN, C., WILLETT, B., KATZ, A., WELCH, J., FOFONOFT, S. and STRONG, M.S., Patterns of relapse in locally advanced-head-and-neck-cancer patients who achieved complete remission after combined modality therapy. Cancer, 56, 1242-1245 (1985).
8. HSU, S.M., RAINE, L. and FANGER, H., Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled-antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580 (1981).
9. JAIN, V., DAS, S.N., LUTHRA, K., SHUKLA, N.K. and RALHAN, R., Differential expression of multidrug-resistance-gene product, p-glycoprotein in normal, dysplastic and malignant oral mucosa in India. Int. J. Cancer, 74, 128-133 (1997).
10. JULIANO, R.L. and LING, V.A., A surface-glycoprotein-modulating drug permeability in Chinese-hamster-ovary cell mutants. Biochim. biophys. Acta, 455, 152-156 (1976).
11. KAUR, J., SRIVASTAVA, A. and RALHAN, R., Over-expression of p53 protein in betel-and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int. J. Cancer, 58, 340-345 (1994).
12. LEIGHTON, J.C. and GOLDSTEIN, L.J., P-glycoprotein in adult solid tumours: expression and prognostic significance. Hematol. Oncol. Clin. North Amer., 9, 251-274 (1995).
13. LOWE, S.W., BODIS, S., MCCLATCHEY, A., REMINGTON, L., RULEY, H.E., FISHER, D.E., HOUSMAN, D.E. and JACKS, T., p53 status and efficacy of cancer therapy in vivo. Science, 266, 807-810 (1994).
14. MACFARLANE, G.J., BOYLE, P., EVSTIFEEVA, T., ROBERSTONE, C. and SCULLY, C., Rising mortality from oral cancer among males worldwide. The return of an old public-health problem. Cancer Causes Control, 5, 259-265 (1994).
15. MARIE, J.P., P-glycoprotein in adult hematologic malignancies. Hematol. Oncol. Clin. North Amer., 9, 243-250 (1995).
16. PINDBORG, J.J., Epidemiological studies of oral cancer. Int. dent. J., 27, 172-176 (1977).
17. RAYBAUD-DIOGENE, H., TETU, B., MORENCY, R., FORTIN, A. and MONTEIL, R.A., p53 over-expression in head-and-neck squamous-cell carcinoma: review of the literature. Oral Oncol. Europ. J. Cancer, 32, 143-149 (1996).
18. RIOU, G., BORROIS, M., PROST, S., TERRIER, M.J., THEODORE, C. and LEVINE, A.J., p53 and mdm2 genes in human testicular-germ-cell tumours. Mol. Carcinog., 12, 124-131 (1995).
19. SANGHAVI, L.D., Epidemiologic and intervention studies, screening cancer epidemiology: the Indian scene. J. Cancer Res. clin. Oncol., 9, 1-14 (1981).
20. TEETER, L.D., ECKERSBERG, T., TSAI, Y. and KUO, M., Analysis of the Chinese hamster p-glycoprotein multidrug-resistance gene Pgp-1 reveals that the AP-1 site is essential for full promoter activity. Cell Growth Differ., 2, 429-437 (1991).
21. VERRELLE, P., MEISSONNIER, F., FONCK, Y., FEILLEL, V., DIONET, C., KWIATKOWSKI, F., PLAGNE, R. and CHASSAGNE, J., Clinical relevance of immunohistochemical detection of multidrug-resistance p-glycoprotein in breast carcinoma. J. nat. Cancer. Inst., 83, 111-116 (1991).
22. VOKE, E.E., WEICHSEIBAUM, R.R., LIPPMAN, S.M. and HONG, W.K., Head-and-neck cancer (see comment citations in medicine). New Engl. J. Med., 328, 184-194 (1993).
23. WATTEL, E., PREUDHOMME, C., HECQUET, B., VANRUMBEKE, M., QUESNEL, B., DERVITE, I., MOREL, P. and FENAUX, P., p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 3148-3157 (1994).
24. WEINSTEIN, R.S., JAKATE, S.M., DOMINQUEZ, J.M., LEBOVITZ, M.D., KOUKOULIS, J.K., KUSZAK, J.R., KLUSENS, L.F., GROGAN, T.M., SACLARIDES, T.J., RONINSON, I. and COON, J.S., Relationship of the expression of the multidrug-resistance-gene product (P-glycoprotein) in human colon carcinoma to local tumour aggressiveness and lymph-node metastasis. Cancer Res., 51, 2720-2726 (1991).